Molecular Neurodegeneration

What topics are covered by the course?

The programme will focus on several disorders including Alzheimerís disease, Parkinsonís disease, Fragile X, Spinocerebellar ataxia and amyotrophic lateral sclerosis. There are many parallels between different neurodegenerative disorders and the course will examine the common themes across neurodegenerative processes. Participants will gain an insight into the current understanding of both rare and common neurological disorders, the strengths and weaknesses of experimental approaches and evidence, and how this knowledge can be applied to develop therapies.

The programme is aimed at individuals working in neurodegenerative research, neurogenetics or translational neuroscience, including clinician scientists, veterinary scientists, PhD students and post-doctoral researchers. We encourage applications from researchers based in the pharmaceutical and biotechnology industries. Applications from those who have completed a PhD in another area and have moved into neuroscience for their postdoctoral studies will also be considered.

The course will benefit researchers who seek a comprehensive view of neurodegenerative disorders together with state of the art research techniques, and who wish to gain a new perspective on their own studies. The intensive programme provides the opportunity to interact with leading international neuroscientists. To optimize discussions and interactions, numbers are limited to 30 students.

The programme is lecture-based but highly interactive. Participants will have the opportunity to share their research with tutors, speakers and other students throughout the course, during the formal poster sessions and discussion sessions.

Topics will include:
- Pathological events in neurodegeneration
- Autophagy, aging and neurodegeneration
- Genetic variation in inherited and sporadic disease
- Use of in vivo models to study neurological pathogenesis
- Modelling neurodegeneration using iPSCs
-Development of therapeutic approaches

Speakers: Scientific programme committee: Sue Ackerman (University of California, San Francisco, USA), Mark Cookson (National Institutes of Health, USA), Beverly Davidson (The Childrenís Hospital of Philadelphia, USA), Harry Orr (University of Minnesota, USA), Nicholas Wood (University College London, UK)

Who should attend?

this course is aimed at and any pre-requisites a potential student

What will I be able to do on completion?

course, molecular, neurodegeneration, treatment strategies, neurodegenerative disorders, alzheimerís disease, parkinsonís disease, fragile x, spinocerebellar ataxia, amyotrophic lateral sclerosis, experimental approaches, evidence, therapies, neurodegenerative research, neurogenetics, translational neuroscience, clinician scientists, veterinary scientists, phd students, post-doctoral researcher, lecture-based, interactive, poster sessions, discussion sessions, pathological events in neurodegeneration, autophagy, aging, genetic variation in inherited and sporadic disease, in vivo models, neurological pathogenesis, modelling neurodegeneration, ipscs, therapeutic approaches, residential

How will I be assessed?

the student given a final exam at the end of the course or is assessment an ongoing process throughout the course

Wellcome Genome Campus Conference Centre, Wellcome Genome Campus, Hinxton, Cambridge, CB10 1RQ, United Kingdom

Guide Price: GBP 0

Delivery: Other
Category: Health & Medical »
Duration: on Monday January 09, 2017 at 12:00 pm (ends Saturday January 14, 2017 at 4:00 pm)

Search for health & medical courses in